Healthy Volunteers Clinical Trial
Official title:
Evaluation of Synergistic Anti-plaque Activity of Salvadora Persica L. and Green Tea: A Clinical Comparative Study
Accumulation of dental plaque may result in negative effects on the tooth and tooth supporting periodontal tissue. In addition, it contributes to the development of caries and periodontal diseases. Therefore, an effective dental plaque control is essential for maintaining good oral hygiene. Mechanical plaque control has its limitation thus chemical plaque control may be used as an adjunct in dental plaque control. Various types of medicinal plants can be utilized as stable, safe and biologically active plant-derived galenicals as alternative to synthetic mouth wash. Among these plants, Salvadora persica L. (Sp) root sticks and green tea (Gt) aqueous extracts were reported to have anti-microbial activity against many oral bacteria. The objective of this study was to investigate the efficacy of the combination of Gt aqueous extract and Sp aqueous extract as a synergistic anti-bacterial and anti-adherence efficacy against primary plaque colonizers.
Dental plaque is the soft deposits that form the biofilm adhering to the tooth surface or
other hard surfaces inside oral cavity, including removable and fixed restoration. The
dental plaque is composed of over 500 bacterial species. The colonization of these bacteria
follows a special pattern starting by adhesion of initial bacterial colonizers to the
salivary pellicles covering tooth enamel and other hard surfaces in the oral cavity followed
by secondary colonization of follower bacteria through inter-bacterial adhesion leading to
dental plaque maturation.
Periodontal health can be considered to be in a state of balance when the bacterial mass
presents in the host oral cavity and causes no damage to either the bacteria or the host
periodontal tissues. Any disruption of this balance results in alterations in both the host
periodontal and biofilm bacteria and leads ultimately to destruction of the periodontium.
Accumulation of dental plaque may lead to several harmful effects on the tooth and tooth
supporting periodontal tissue that contributes to the development of caries and periodontal
diseases. Therefore, an effective dental plaque control is essential for maintaining good
oral hygiene.
Mechanical plaque control, by using toothbrushes and interdental aids, is the mostly adopted
method. Unfortunately, it is a time consuming process and needs high manual dexterity.
Moreover, epidemiological studies revealed high prevalence of gingivitis among toothbrush
users. Hence, chemical plaque control may be used to assist in dental plaque control.
The anti-plaque agent is that agent that interferes with one of the different phases of
dental plaque development: interferes with the adhesion of oral bacteria to oral surfaces
and prevent biofilm formation; interferes with co-aggregation mechanism which thereby
prevents future growth of micro-colonies; or removes or disrupts existing dental plaque. To
date, chlorhexidine (CHX) mouthwash is the standard solution used in chemical plaque
control, but it was found to have several side effects including tooth and some restorations
staining, unpleasant test, sloughing of oral mucosa and enhancement of supra-gingival
calculus formation.
The widely available traditional natural medicinal plants can be utilized as stable, safe
and biologically active plant-derived galenicals as alternative to synthetic drugs. Among
these plants, Salvadora persica L. (Sp) root sticks and green tea (Gt), leafs of Camellia
sinensis. Kuntze, aqueous extracts were reported to have anti-microbial activity against
many oral bacteria. In our in vitro study, we found that the combination (Co.) of 0.25mg Gt
aqueous extract and 7.82mg Sp aqueous extract in 1ml exhibited significant synergistic
anti-bacterial and anti-adherence efficacy against primary plaque colonizers.
The dental plaque is classified into two categories, supra-gingival plaque and sub-gingival
plaque, in relation to gingival margin. The supra-gingival dental plaque may be readily
visualized on teeth after 24 to 48 hours with no oral hygiene measures and it appears white,
grayish, or yellow in color and has a globular appearance.
Supra-gingival plaque accumulation on tooth surfaces can be quantified through different
plaque index systems. In this study, the clinical parameter to record plaque quantity was
modified Quigely Hein Plaque Index. In this index, a score of 0 to 5 was assigned for each
facial and lingual (palatal) surface of all teeth except the third molars.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |